Rituximab Plus Bortezomib for Relapsed and Refractory Warm Autoimmune Hemolytic Anemia: A Prospective Phase 2 Trial. Lin X, Yang C, Zhuang J, Li J, et al. Am J Hematol 2024 Dec 21. doi: 10.1002/ajh.27540.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin X, Yang C, Zhuang J, Li J, et al. Rituximab Plus Bortezomib for Relapsed and Refractory Warm Autoimmune Hemolytic Anemia: A Prospective Phase 2 Trial. Am J Hematol 2024 Dec 21. doi: 10.1002/ajh.27540.
PMID: 39708374